| scholarly article | Q13442814 |
| P50 | author | Luiz Fernando Quintanilha | Q62769158 |
| P2093 | author name string | Bianca Gutfilen | |
| Regina C S Goldenberg | |||
| Christina M Takiya | |||
| Lea Mirian B Fonseca | |||
| Bruno D Paredes | |||
| Antonio Carlos Campos de Carvalho | |||
| Felipe G Carvalho | |||
| Guilherme F M Rezende | |||
| Adriana B Carvalho | |||
| Juliana V Dias | |||
| Karina D Asensi | |||
| Celia Maria C Resende | |||
| Elida G Mannheimer | |||
| P433 | issue | 5 | |
| P304 | page(s) | 1307-1314 | |
| P577 | publication date | 2008-02-28 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury | |
| P478 | volume | 26 |
| Q42419252 | 99m-Technetium binding site in bone marrow mononuclear cells |
| Q41526136 | A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis |
| Q30318258 | A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation |
| Q38481817 | Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. |
| Q42708757 | Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury |
| Q64261009 | BMSC Transplantation Aggravates Inflammation, Oxidative Stress, and Fibrosis and Impairs Skeletal Muscle Regeneration |
| Q46265702 | Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. |
| Q33521757 | Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model. |
| Q35651211 | Bone marrow mesenchymal cells improve muscle function in a skeletal muscle re-injury model |
| Q50688665 | Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. |
| Q43053700 | Bone marrow mononuclear cells shift bioactive lipid pattern in injured kidney towards tissue repair in rats with unilateral ureteral obstruction |
| Q36509141 | Bone marrow progenitor cells do not contribute to liver fibrogenic cells |
| Q40204776 | Cell Therapy Using Adipose-Derived Stem Cells for Chronic Liver Injury in Mice |
| Q36353622 | Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis. |
| Q37574218 | Current status of stem cell therapy for liver diseases |
| Q85232866 | Decreased collagen types I and IV, laminin, CK-19 and α-SMA expression after bone marrow cell transplantation in rats with liver fibrosis |
| Q52874172 | Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection. |
| Q37627487 | Enhancement of Bone-Marrow-Derived Mesenchymal Stem Cell Angiogenic Capacity by NPWT for a Combinatorial Therapy to Promote Wound Healing with Large Defect |
| Q33494039 | Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver |
| Q35667434 | Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway |
| Q38205960 | Hepatic progenitor cells in liver regeneration: current advances and clinical perspectives |
| Q33722100 | Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators |
| Q36501694 | Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway |
| Q41571526 | Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden synthetic hydrogels |
| Q37729256 | Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases |
| Q39024740 | Induction of mesenchymal stem cell differentiation in the absence of soluble inducer for cutaneous wound regeneration by a chitin nanofiber-based hydrogel. |
| Q34202877 | Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis |
| Q42592741 | Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis |
| Q30453566 | Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats |
| Q60912891 | Liver Macrophage Depletion Ameliorates The Effect of Mesenchymal Stem Cell Transplantation in a Murine Model of Injured Liver |
| Q51243575 | Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway. |
| Q35905940 | Mesenchymal Bone Marrow-derived Stem Cells Transplantation in Patients with HCV Related Liver Cirrhosis |
| Q35061477 | Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice. |
| Q37721430 | Mesenchymal Stem Cells Transplantation following Partial Hepatectomy: A New Concept to Promote Liver Regeneration-Systematic Review of the Literature Focused on Experimental Studies in Rodent Models |
| Q36560851 | Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively |
| Q51713351 | Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis. |
| Q26769618 | Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease |
| Q36165804 | Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis |
| Q37649563 | Potentials of regenerative medicine for liver disease |
| Q28543219 | Prevention of liver fibrosis by intrasplenic injection of high-density cultured bone marrow cells in a rat chronic liver injury model |
| Q47439158 | Prolonged survival by combined treatment with granulocyte colony-stimulating factor and dipeptidyl peptidase IV inhibitor in a rat small-for-size liver transplantation model. |
| Q38159684 | Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure |
| Q37395901 | Stem cell researches in Brazil: present and future challenges |
| Q35105028 | Stem cells and liver regeneration. |
| Q34116253 | Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis |
| Q37974210 | Therapeutic implications of mesenchymal stem cells in liver injury |
| Q52667755 | Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure. |
| Q50455613 | Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis. |
| Q35006127 | Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosis |
| Q42955563 | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI |
| Q30482717 | Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats |
| Q37572913 | Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapy |
| Q59337400 | Yiguanjian decoction enhances fetal liver stem/progenitor cell-mediated repair of liver cirrhosis through regulation of macrophage activation state |
Search more.